Physician profile
Georgios Syros
NPI 1295065993
$13,315.95
in general payments reported to CMS, 2019-2025
30 companies · $1,855 in 2025
The $1,855 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,665 · 2020: $928 · 2021: $1,046 · 2022: $1,254 · 2023: $2,304 · 2024: $3,264 · 2025: $1,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,012 · Travel and Lodging: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,011.73 |
| Travel and Lodging | $1,411.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,050.20 | 2019-2025 | Watchman Access System, Watchman Flx, Bodyguardian |
| Abbott Laboratories | $1,947.94 | 2019-2025 | Aveir, Perclose Proglide, Pressurewire |
| Medtronic, INC. | $1,633.16 | 2021-2025 | Hawkone, Micra, Linq II |
| Janssen Pharmaceuticals, INC | $1,057.81 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $632.30 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $519.12 | 2021-2023 | Lokelma |
| Irhythm Technologies, INC. | $408.57 | 2019-2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Novartis Pharmaceuticals Corporation | $387.78 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.53 | 2019-2025 | Jardiance |
| Zoll Medical Corporation | $300.00 | 2020 | |
| Amgen INC. | $295.56 | 2023-2025 | Repatha, Repatha |
| Vifor Pharma, INC. | $249.98 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $219.38 | 2023-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $153.11 | 2019-2020 | |
| Nevro Corp. | $139.76 | 2023 | Senza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $134.65 | 2021 | |
| Itamar Medical INC | $125.00 | 2022-2023 | Watchpatone |
| Atricure, INC. | $117.32 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.80 | 2019 | |
| Stereotaxis INC | $83.33 | 2022 | |
| Heartflow, INC. | $72.69 | 2024 | |
| Cardiva Medical, INC. | $70.07 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $62.55 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $52.07 | 2023-2024 | Amvuttra |
| Tactile Systems Technology INC | $27.98 | 2025 | Flexitouch Plus, Nimbl |
| Biotronik INC. | $24.92 | 2021 | |
| Chiesi USA, INC. | $24.63 | 2024 | Kengreal, Cleviprex |
| Preventice Services, LLC | $21.82 | 2020 | |
| Merck Sharp & Dohme LLC | $20.58 | 2025 | Verquvo |
| Bardy Diagnostics, INC. | $8.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgios Syros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.